Published in Int J Pediatr on November 03, 2011
The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol (2014) 0.90
Invasive candidiasis and oral manifestations in premature newborns. Einstein (Sao Paulo) (2013) 0.80
Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients. Infect Drug Resist (2016) 0.75
Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics (2002) 9.87
Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics (2006) 3.78
Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J (2000) 3.13
Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis (1995) 2.74
National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis (1999) 2.63
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics (2006) 2.10
Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis (1994) 2.04
Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J (1998) 1.88
Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics (2010) 1.86
Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics (2003) 1.86
Volume of blood submitted for culture from neonates. J Clin Microbiol (1986) 1.77
Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol (2004) 1.64
When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics (2000) 1.58
The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest (1997) 1.49
Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol (2002) 1.49
Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J (2001) 1.44
Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis (1996) 1.31
Bacterial concentration and blood volume required for a positive blood culture. J Perinatol (1995) 1.27
Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J (1987) 1.19
Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis (1988) 1.14
Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics (2001) 1.10
Systemic candidiasis: a study of 109 fatal cases. Pediatr Infect Dis (1983) 1.04
Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J (2000) 1.00
Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J (1992) 0.99
Risk factors for breakthrough candidemia. Eur J Clin Microbiol Infect Dis (2002) 0.99
Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol (1998) 0.97
Candida infections in the neonate. Curr Opin Pediatr (2003) 0.91
Nosocomial infections in the neonatal intensive care unit. Curr Opin Infect Dis (2001) 0.88
Time to positive culture results in neonatal Candida septicemia. J Pediatr (2003) 0.88
Fungemia in neonates: report of 80 cases from seven University hospitals. Pediatrics (2000) 0.86
Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr (1994) 0.81
Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection. Pediatrics (2008) 1.47
Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis (2004) 1.37
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J (2003) 1.11
Clearance of Cellulosimicrobium cellulans bacteremia in a child without central venous catheter removal. J Clin Microbiol (2006) 1.09
Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART). Eur J Pediatr (2006) 0.89
Aureobasidium pullulans var. melanigenum fungemia in a pediatric patient. Med Mycol (2010) 0.87
Sepsis with prolonged hypotension due to Moraxella osloensis in a non-immunocompromised child. J Med Microbiol (2010) 0.86
Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. J Clin Microbiol (2013) 0.83
HIV-1 phenotypic drug resistance testing among highly treatment experienced and poorly adherent youth. Pediatr Infect Dis J (2013) 0.83
Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis. Pediatr Infect Dis J (2013) 0.81
Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. J Acquir Immune Defic Syndr (2010) 0.80
Pneumocephalus and presumed meningitis following inconspicuous penetrating periocular trauma. Acta Ophthalmol Scand (2004) 0.79
Autologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART. AIDS Res Hum Retroviruses (2010) 0.78
Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy. Pediatr Res (2007) 0.78
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. J Antimicrob Chemother (2010) 0.76
The changing epidemiology of methicillin-resistant Staphylococcus aureus in pediatric wound cultures: a 10-year experience. Clin Pediatr (Phila) (2012) 0.75
Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies. Int J Clin Pharmacol Ther (2015) 0.75
Morbidity and Mortality of a Cohort of Peruvian HIV-Infected Children 2003-2012. Pediatr Infect Dis J (2017) 0.75
Real-time fluorescence polymerase chain reaction (PCR) identification of Streptococcus pneumoniae from pleural fluid and tissue. Scand J Infect Dis (2005) 0.75
Pharmacokinetics of tenofovir alafenamide with boosted protease inhibitors in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s. J Acquir Immune Defic Syndr (2022) 0.75
Herpes Zoster Meningitis Presenting With a Cerebrospinal Fluid Leukemoid Reaction in an Adolescent With preB-ALL in Remission. J Pediatr Hematol Oncol (2016) 0.75